Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1076 (1 May), doi:10.1136/bmj.328.7447.1076-a
| The first 150 words of the full text of this article appear below. |
EDITORThe prevalence of aspirin induced asthma on oral provocation testing in the systematic review by Jenkins et al was determined at 21%, which is noticeably higher than verbal history (2-3%) and recent reviews (10%).1-3 The clinical relevance of this finding is not explained. What was the degree of bronchospasm? In how many patients was it easily reversed by a dose of inhaler?
|
|
Credit: BAYER AG
|
As anaesthetists we agree fully with the authors' recommendations about the dangers of giving non-steroidal anti-inflammatory drugs (NSAIDs) to patients with known sensitivity to aspirin. We also recognise that people with nasal polyps and asthma are at higher risk of aspirin sensitivity. It is the large proportion of patients who are left for whom we have an issue.
The recommendation to organise a test before administration would be difficult in the current NHS. The authors' guidelines recommend that anyone younger than 40 should
Indu Sivanandan, clinical fellow anaesthetics
sindu@doctors.org.uk
Stephen M Robinson, consultant anaesthetist
Southmead Hospital, Bristol BS10 5NB